Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2011-08-31
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
\*Main hypothesis: Art therapy has no impact on clinical symptoms and the course of remission compared to TAU.
\*Exploratory hypotheses: Art therapy has no influence on quality of life, mentalizing function, self-efficacy and neuroleptic dosage compared to TAU.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficiency of Art-therapy in Psychotic Disorders
NCT02383095
Modified Psychodynamic Psychotherapy for Patients With Schizophrenia
NCT02576613
Dance and Movement Therapy in Patients With Schizophrenia
NCT05500651
Delusion Ideation in the Context of Everyday Life
NCT06207526
Brain Activation Patterns in Schizophrenia After Computerized Cognitive Skills Training
NCT00431223
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
art therapy
12 sessions of art therapy / 6 weeks
psychodynamic art therapy
2 sessions à 1.5 hrs /week, intervention duration 6 weeks
TAU
treatment as usual / 6 weeks
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
psychodynamic art therapy
2 sessions à 1.5 hrs /week, intervention duration 6 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 18-64 yrs
* sufficient German language competency
* written informed consent
Exclusion Criteria
* comorbid antisocial personality disorder, relevant substance abuse,
* relevant severe somatic disease
* acute suicidal tendencies or aggression
* incapability to tolerate group settings
18 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prof. K. Dannecker, Kunsttherapie Berlin Kunsthochschule Berlin-Weißensee
UNKNOWN
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christiane Montag MD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christiane Montag, M.D.
Role: PRINCIPAL_INVESTIGATOR
Charite University, Berlin, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Psychiatrische Universitätsklinik der Charité im St. Hedwig Krankenhaus
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Montag C, Haase L, Seidel D, Bayerl M, Gallinat J, Herrmann U, Dannecker K. A pilot RCT of psychodynamic group art therapy for patients in acute psychotic episodes: feasibility, impact on symptoms and mentalising capacity. PLoS One. 2014 Nov 13;9(11):e112348. doi: 10.1371/journal.pone.0112348. eCollection 2014.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EA1/104/11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.